Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ashley Bayer

Pediatrics Coral Springs, FL Doctor of Osteopathy

NPI 1376794982 CMS profile 1382884

8150 Royal Palm Blvd Ste 105, Coral Springs, FL 33065

Open in the dashboard

General payments

$2,547

138 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ashley Bayer of Coral Springs, FL is reported in the CMS Open Payments database as having received $2,547 across 138 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $309 15
2024 General $286 16
2023 General $275 15
2022 General $555 34
2021 General $557 33
2020 General $300 15
2019 General $265 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ashley Bayer
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Ashley Bayer were reported at $309. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Ashley Bayer Pediatrics median Middle half National median
2019 $265 $86 $31–$183 $163
2020 $300 $49 $22–$110 $114
2021 $557 $68 $27–$158 $132
2022 $555 $77 $30–$173 $149
2023 $275 $88 $33–$190 $160
2024 $286 $94 $34–$206 $164
2025 $309 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corium, Inc. $395 28 payments
  2. Tris Pharma Inc $373 23 payments
  3. Pfizer Inc. $353 13 payments
  4. GlaxoSmithKline, LLC. $243 12 payments
  5. Ironshore Pharmaceuticals Inc. $209 11 payments
  6. Takeda Pharmaceuticals U.S.A., Inc. $178 14 payments
  7. Cranial Technologies, Inc $124 8 payments
  8. AbbVie, Inc. $114 1 payment
  9. Merck Sharp & Dohme Corporation $104 5 payments
  10. Neurelis, Inc. $63 3 payments
  11. Other $390 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,547 138 payments
Products named General payments · program years 2019–2025
  1. Azstarys $395 28 payments
  2. EUCRISA $288 10 payments
  3. Dyanavel XR Adhd $237 16 payments
  4. BEXSERO $226 11 payments
  5. VYVANSE $202 15 payments
  6. Doc Band $124 8 payments
  7. HUMIRA $114 1 payment
  8. JORNAY PM $104 5 payments
  9. Dyanavel XR Adhd $101 5 payments
  10. VAQTA $90 4 payments
  11. Other $1,399 72 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

138 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record